Market Cap 243.14M
Revenue (ttm) 71.61M
Net Income (ttm) -48.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -67.85%
Debt to Equity Ratio -1.68
Volume 1,420,000
Avg Vol 489,472
Day's Range N/A - N/A
Shares Out 30.78M
Stochastic %K 94%
Beta 1.86
Analysts Strong Sell
Price Target $9.00

Company Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to...

Industry: Medical Devices
Sector: Healthcare
Phone: 661 367 9170
Fax: 661 367 9180
Address:
28159 Avenue Stanford, Suite 220, Valencia, United States
Lambster2
Lambster2 Aug. 19 at 8:30 AM
$RCEL Cowen ups PT to 14 after KOL webinar. Avita Medical (NASDAQ: RCEL) Buy (1) Price Target: $14.00 (Prior $12.00) KOL Webinar Increases Our Confidence In PermeaDerm's Commercial Potential THE TD COWEN INSIGHT Avita hosted a KOL webinar to discuss PermeaDerm I clinical trial data, which showed a clear economic benefit vs. allograft with comparable clinical outcomes. Overall, the KOL discussion further reinforced our view that the new clinical data should catalyze stronger PermeaDerm adoption trends; we believe PermeaDerm represents an essential component of Avita's burn-care ecosystem. Reiterate Buy.
0 · Reply
Innerchild
Innerchild Aug. 19 at 4:13 AM
$GDC Has Damon been right all along? Am I fucked and will end in debt? Chatgpt says so, read the picture: $WEAV $RCEL $SCTX $OBIO
0 · Reply
Lambster2
Lambster2 Aug. 19 at 2:44 AM
$RCEL Avita Medical (NASDAQ: RCEL) Buy (1) Price Target: $12.00 PermeaDerm I Data Should Catalyze Stronger Adoption Trends; Webinar at 4:30p ET THE TD COWEN INSIGHT This morning, Avita announced data from its PermeaDerm I study, which demonstrated a clear economic benefit vs. allograft while providing similar clinical outcomes. We believe the data should support further PermeaDerm commercialization and help Avita deepen penetration within its hospital network. The company is hosting a webinar at 4:30pm ET with two KOLs to discuss the results. Reiterate Buy.
0 · Reply
DonJ2024
DonJ2024 Aug. 18 at 9:53 PM
$RCEL sell the news and get back in again
0 · Reply
JHR
JHR Aug. 18 at 9:49 PM
$RCEL It was supposed to go back to 6. I just want a chance to party again
0 · Reply
STACKD0E
STACKD0E Aug. 18 at 8:32 PM
$RCEL 🙃 ✨️
0 · Reply
topstockalerts
topstockalerts Aug. 18 at 8:08 PM
$RCEL this one keeps passing every test
0 · Reply
History101
History101 Aug. 18 at 8:04 PM
$SLS I love it when it's a red market day, and ALL of my portfolios, headed by SLS, are GREEN!! $REPL $OTLK $RCEL $IMMX
1 · Reply
jacksparo
jacksparo Aug. 18 at 8:02 PM
$RCEL Another one got a great winning mark . From my emails 📈✅📈✅!
1 · Reply
Salsolstudio
Salsolstudio Aug. 18 at 7:46 PM
1 · Reply
Latest News on RCEL
AVITA Medical Transcript: KOL event

Aug 18, 2026, 4:30 PM EDT - 15 hours ago

AVITA Medical Transcript: KOL event


AVITA Medical Press release: KOL event

Aug 18, 2026, 4:30 PM EDT - 15 hours ago

AVITA Medical Press release: KOL event


AVITA Medical Slides: KOL event

Aug 18, 2026, 4:30 PM EDT - 15 hours ago

AVITA Medical Slides: KOL event


AVITA Medical Transcript: Investor update

Aug 12, 2026, 7:00 PM EDT - 6 days ago

AVITA Medical Transcript: Investor update


AVITA Medical Slides: Investor update

Aug 12, 2026, 7:00 PM EDT - 6 days ago

AVITA Medical Slides: Investor update


AVITA Medical to Host Investor Webinar Briefing

Aug 9, 2026, 6:00 PM EDT - 9 days ago

AVITA Medical to Host Investor Webinar Briefing


Avita Medical upgraded to Buy from Neutral at BTIG

2026-08-07T10:50:20.000Z - 12 days ago

Avita Medical upgraded to Buy from Neutral at BTIG


Avita Medical reports Q2 EPS (25c), consensus (39c)

2026-08-06T20:46:26.000Z - 12 days ago

Avita Medical reports Q2 EPS (25c), consensus (39c)


AVITA Medical Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

AVITA Medical Earnings Call Transcript: Q2 2026


AVITA Medical Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

AVITA Medical Earnings release: Q2 2026


AVITA Medical Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

AVITA Medical Quarterly report: Q2 2026


AVITA Medical Slides: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

AVITA Medical Slides: Q2 2026


AVITA Medical to Announce Second Quarter 2026 Financial Results

Jul 14, 2026, 4:05 PM EDT - 5 weeks ago

AVITA Medical to Announce Second Quarter 2026 Financial Results


Avita Medical management to meet virtually with Lake Street

2026-06-16T21:00:28.000Z - 2 months ago

Avita Medical management to meet virtually with Lake Street


AVITA Medical Transcript: Status update

May 20, 2026, 7:00 PM EDT - 3 months ago

AVITA Medical Transcript: Status update


Avita Medical upgraded to Buy from Hold at Lake Street

2026-05-15T14:04:59.000Z - 3 months ago

Avita Medical upgraded to Buy from Hold at Lake Street


Avita Medical reports Q1 EPS (35c), consensus (38c)

2026-05-14T21:16:14.000Z - 3 months ago

Avita Medical reports Q1 EPS (35c), consensus (38c)


AVITA Medical Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

AVITA Medical Earnings Call Transcript: Q1 2026


AVITA Medical Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

AVITA Medical Earnings release: Q1 2026


AVITA Medical Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

AVITA Medical Quarterly report: Q1 2026


AVITA Medical Slides: Q1 2026

May 14, 2026, 4:30 PM EDT - 3 months ago

AVITA Medical Slides: Q1 2026


AVITA Medical Reports First Quarter 2026 Financial Results

May 14, 2026, 4:05 PM EDT - 3 months ago

AVITA Medical Reports First Quarter 2026 Financial Results


Avita Medical appoints Cary Vance as CEO

2026-04-30T19:27:03.000Z - 3 months ago

Avita Medical appoints Cary Vance as CEO


AVITA Medical Names Cary Vance as Chief Executive Officer

Apr 30, 2026, 8:50 AM EDT - 3 months ago

AVITA Medical Names Cary Vance as Chief Executive Officer


Avita Medical receives regulatory clearance for Recell Go

2026-04-29T21:09:12.000Z - 3 months ago

Avita Medical receives regulatory clearance for Recell Go


AVITA Medical to Announce First Quarter 2026 Financial Results

Apr 23, 2026, 4:10 PM EDT - 4 months ago

AVITA Medical to Announce First Quarter 2026 Financial Results


AVITA Medical Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

AVITA Medical Proxy statement: Proxy filing


AVITA Medical Transcript: KOL event

Apr 16, 2026, 4:30 PM EDT - 4 months ago

AVITA Medical Transcript: KOL event


AVITA Medical Slides: KOL event

Apr 16, 2026, 4:30 PM EDT - 4 months ago

AVITA Medical Slides: KOL event


AVITA Medical, Inc. Investigated by the Portnoy Law Firm

Apr 13, 2026, 9:00 AM EDT - 4 months ago

AVITA Medical, Inc. Investigated by the Portnoy Law Firm


Avita Medical secures 10-year BARDA agreement worth $25.5M

2026-04-08T20:21:41.000Z - 4 months ago

Avita Medical secures 10-year BARDA agreement worth $25.5M


AVITA Medical Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 4 months ago

AVITA Medical Proxy statement: Proxy filing


AVITA Medical Registration statement: Registration filing

Mar 31, 2026, 8:00 AM EDT - 5 months ago

AVITA Medical Registration statement: Registration filing


Avita Medical initiated with an Outperform at Northland

2026-03-05T14:13:45.000Z - 5 months ago

Avita Medical initiated with an Outperform at Northland


Avita Medical initiated with an Outperform at Northland

2026-03-05T12:51:41.000Z - 5 months ago

Avita Medical initiated with an Outperform at Northland


AVITA Medical Transcript: Status update

Feb 18, 2026, 5:00 PM EST - 6 months ago

AVITA Medical Transcript: Status update


AVITA Medical Slides: Status update

Feb 18, 2026, 5:00 PM EST - 6 months ago

AVITA Medical Slides: Status update


Avita Medical reports Q4 EPS (38c), consensus (55c)

2026-02-12T21:55:45.000Z - 6 months ago

Avita Medical reports Q4 EPS (38c), consensus (55c)


Avita Medical sees FY26 revenue $80M-$85M, consensus $123.5M

2026-02-12T21:55:18.000Z - 6 months ago

Avita Medical sees FY26 revenue $80M-$85M, consensus $123.5M


AVITA Medical Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

AVITA Medical Earnings Call Transcript: Q4 2025


AVITA Medical Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

AVITA Medical Annual report: Q4 2025


AVITA Medical Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

AVITA Medical Earnings release: Q4 2025


AVITA Medical Slides: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

AVITA Medical Slides: Q4 2025


AVITA Medical Announces Changes to its Board of Directors

Jan 5, 2026, 4:05 PM EST - 8 months ago

AVITA Medical Announces Changes to its Board of Directors


AVITA Medical Transcript: Status Update

Nov 12, 2025, 5:00 PM EST - 9 months ago

AVITA Medical Transcript: Status Update


AVITA Medical Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

AVITA Medical Earnings Call Transcript: Q3 2025


AVITA Medical Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

AVITA Medical Quarterly report: Q3 2025


AVITA Medical Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

AVITA Medical Earnings release: Q3 2025


AVITA Medical Slides: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

AVITA Medical Slides: Q3 2025


AVITA Medical to Announce Third Quarter 2025 Financial Results

Oct 29, 2025, 4:15 PM EDT - 10 months ago

AVITA Medical to Announce Third Quarter 2025 Financial Results


AVITA Medical Welcomes Support for RECELL® in Burns in Australia

Oct 28, 2025, 4:30 PM EDT - 10 months ago

AVITA Medical Welcomes Support for RECELL® in Burns in Australia


AVITA Medical Announces CEO Transition

Oct 16, 2025, 6:15 PM EDT - 10 months ago

AVITA Medical Announces CEO Transition


AVITA Medical Successfully Completes Australian Equity Raise

Aug 12, 2025, 8:30 AM EDT - 1 year ago

AVITA Medical Successfully Completes Australian Equity Raise


AVITA Medical Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Earnings Call Transcript: Q2 2025


AVITA Medical Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Quarterly report: Q2 2025


AVITA Medical Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Earnings release: Q2 2025


AVITA Medical Slides: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Slides: Q2 2025


AVITA Medical Transcript: Status Update

May 13, 2025, 2:00 PM EDT - 1 year ago

AVITA Medical Transcript: Status Update


AVITA Medical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Earnings Call Transcript: Q1 2025


AVITA Medical Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Quarterly report: Q1 2025


AVITA Medical Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Earnings release: Q1 2025


AVITA Medical Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Slides: Q1 2025


AVITA Medical Reports First Quarter 2025 Financial Results

May 8, 2025, 4:03 PM EDT - 1 year ago

AVITA Medical Reports First Quarter 2025 Financial Results


AVITA Medical Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

AVITA Medical Proxy statement: Proxy Filing


AVITA Medical Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

AVITA Medical Proxy statement: Proxy Filing


AVITA Medical Transcript: Investor Update

Feb 18, 2025, 5:00 PM EST - 1 year ago

AVITA Medical Transcript: Investor Update


AVITA Medical Earnings Call Transcript: Q4 2024

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Earnings Call Transcript: Q4 2024


AVITA Medical Annual report: Q4 2024

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Annual report: Q4 2024


AVITA Medical Earnings release: Q4 2024

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Earnings release: Q4 2024


AVITA Medical Slides: Q4 2024

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Slides: Q4 2024


AVITA Medical's shares sink 19% after another forecast cut

Jan 7, 2025, 10:12 PM EST - 1 year ago

AVITA Medical's shares sink 19% after another forecast cut


Lambster2
Lambster2 Aug. 19 at 8:30 AM
$RCEL Cowen ups PT to 14 after KOL webinar. Avita Medical (NASDAQ: RCEL) Buy (1) Price Target: $14.00 (Prior $12.00) KOL Webinar Increases Our Confidence In PermeaDerm's Commercial Potential THE TD COWEN INSIGHT Avita hosted a KOL webinar to discuss PermeaDerm I clinical trial data, which showed a clear economic benefit vs. allograft with comparable clinical outcomes. Overall, the KOL discussion further reinforced our view that the new clinical data should catalyze stronger PermeaDerm adoption trends; we believe PermeaDerm represents an essential component of Avita's burn-care ecosystem. Reiterate Buy.
0 · Reply
Innerchild
Innerchild Aug. 19 at 4:13 AM
$GDC Has Damon been right all along? Am I fucked and will end in debt? Chatgpt says so, read the picture: $WEAV $RCEL $SCTX $OBIO
0 · Reply
Lambster2
Lambster2 Aug. 19 at 2:44 AM
$RCEL Avita Medical (NASDAQ: RCEL) Buy (1) Price Target: $12.00 PermeaDerm I Data Should Catalyze Stronger Adoption Trends; Webinar at 4:30p ET THE TD COWEN INSIGHT This morning, Avita announced data from its PermeaDerm I study, which demonstrated a clear economic benefit vs. allograft while providing similar clinical outcomes. We believe the data should support further PermeaDerm commercialization and help Avita deepen penetration within its hospital network. The company is hosting a webinar at 4:30pm ET with two KOLs to discuss the results. Reiterate Buy.
0 · Reply
DonJ2024
DonJ2024 Aug. 18 at 9:53 PM
$RCEL sell the news and get back in again
0 · Reply
JHR
JHR Aug. 18 at 9:49 PM
$RCEL It was supposed to go back to 6. I just want a chance to party again
0 · Reply
STACKD0E
STACKD0E Aug. 18 at 8:32 PM
$RCEL 🙃 ✨️
0 · Reply
topstockalerts
topstockalerts Aug. 18 at 8:08 PM
$RCEL this one keeps passing every test
0 · Reply
History101
History101 Aug. 18 at 8:04 PM
$SLS I love it when it's a red market day, and ALL of my portfolios, headed by SLS, are GREEN!! $REPL $OTLK $RCEL $IMMX
1 · Reply
jacksparo
jacksparo Aug. 18 at 8:02 PM
$RCEL Another one got a great winning mark . From my emails 📈✅📈✅!
1 · Reply
Salsolstudio
Salsolstudio Aug. 18 at 7:46 PM
1 · Reply
TXDave
TXDave Aug. 18 at 7:38 PM
$RCEL It's a fight at $10! Love it. The progress under Vance, amazing, great job executing. I was worried it was too late. Sure in hindsight should've loaded the truck in the $3 and $4 range but didn't . Happy for the ride up. All my bio stocks are killing it, the sector is doing well. $244M market cap for what they have seems very reasonable cheap. Cashflow positive Q4. Had to add a bit under $10 but now will hold and look for $30 to $40 range before selling. Could take a while but will be pissed if they sell under $25. This is just too cool of a package. Will move into elective and vitiligo and then Katie bar the doors.
0 · Reply
Salsolstudio
Salsolstudio Aug. 18 at 7:12 PM
1 · Reply
RTPRwire
RTPRwire Aug. 18 at 6:21 PM
$RCEL is moving on clinical trial results following a Globe Newswire release. AVITA Medical's PermeaDerm study achieved primary endpoint, showing 70% cost advantage over allograft with comparable clinical outcomes and 96% faster preparation time. RTPR pushed this release out to users at 7:45:00 AM ET
0 · Reply
healthcareguru
healthcareguru Aug. 18 at 6:20 PM
$RCEL Pure Comedy!! 😂🤦‍♂️👎 Shorting this piggy every day until it’s <$5 again. Clown sh!t. $XLV $XBI $IWM
1 · Reply
JuliaWarhol15
JuliaWarhol15 Aug. 18 at 6:17 PM
0 · Reply
Biostock
Biostock Aug. 18 at 5:48 PM
$RCEL Let's go $QQQ $SPY
0 · Reply
JuliaWarhol15
JuliaWarhol15 Aug. 18 at 5:30 PM
$RCEL Booyah!!
0 · Reply
All_City_Baby
All_City_Baby Aug. 18 at 5:29 PM
$RCEL Avita has revamped their website. https://avitamedical.com/
1 · Reply
Wats_Up
Wats_Up Aug. 18 at 4:37 PM
$RCEL I continue to be batting around 150 with my predictions. Very happy about being wrong - again.
0 · Reply
josegodoy
josegodoy Aug. 18 at 4:31 PM
$RCEL and the quarterback is toast!!!
0 · Reply
STACKD0E
STACKD0E Aug. 18 at 4:27 PM
$RCEL 🙃 ✨️
0 · Reply
okeydokey_artichokey
okeydokey_artichokey Aug. 18 at 4:20 PM
$RCEL Boom-shaka-laka!!
0 · Reply